Chargement en cours...
Nodal Involvement: Positive about the Role of the Recurrence Score in Estrogen Driven Breast Cancer?
It remains unclear whether there is clinical utility for withholding chemotherapy in HR+/HER2-, node-positive breast cancer based upon the 21-gene Recurrence Score. While we await the results from randomized, phase III trials, this editorial addresses additional observational data that suggest there...
Enregistré dans:
| Publié dans: | Cancer |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329661/ https://ncbi.nlm.nih.gov/pubmed/30387877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31814 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|